← All organizations

Highest phase reached
Phase 4
First clinical trial
May 1, 2016Last known activity
Jun 5, 2023
Acquired by Nautic Partners on Jan 1, 2013
Timeline
1980s
- Dec 22, 1988
ethanolamine— NDA Organization
1990s
- Apr 9, 1998
sacrosidase— NDA Secondary Org
2000s
- Jun 1, 2003
QOL Medical, LLC— Founded
2010s
- Jan 1, 2013
Nautic Partners— Acquired By
Drugs by trial phase (1 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (2)
Recent trials (6)
- NCT05703009Lead sponsorPhase 2Jun 5, 2023
- NCT05703009Overall official - principal investigatorPhase 2Jun 5, 2023
- NCT05480761Lead sponsorPhase 4Aug 1, 2022
- NCT05480761Overall official - principal investigatorPhase 4Aug 1, 2022
- NCT04604275CollaboratorPhase 2Jan 1, 2022
- NCT02784067Lead sponsorPhase 4May 1, 2016
Details
- Founded
- Vero Beach, FL, US Jun 1, 2003
- Last known activity
- Jun 5, 2023
Designations held
- Orphan drug
- Priority review